We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Noramco

News List

Noramco Announces Submission of Drug Master File for Lisdexamfetamine Dimesylate AmericanPharmaceuticalReview
December 06, 2021
Noramco, LLC, a leading North American producer of controlled substance bulk Active Pharmaceutical Ingredients (APIs) for the pharmaceutical industry, today announced it has submitted a Type II Drug Master File (DMF) to the U.S. Food and Drug...
Noramco, SPI Pharma Announce Availability of Excipient Compatibility Study for Cannabidiol Solid Oral Dosage Forms americanpharmaceuticalreview
July 10, 2019
Noramco and SPI Pharma announced they have completed work on an excipient compatibility study examining a range of options for the development of cannabidiol (CBD) solid oral dosage forms ...
Partnership struck to increase production of DEA controlled substances cphi-online
March 19, 2018
Noramco selects AFC for its infrastructure and analytical capabilities to help meet growing demand.